Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Montanova Capital, LLC reported a 5.50% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Montanova Capital, LLC reported a 5.50% stake in Fulcrum Therapeutics, Inc., 3,680,921 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 3,680,921
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Montanova Capital, LLC | 5.50% | 3,680,921 |
| Averill Master Fund, Ltd. | 3.80% | 2,553,201 |
| Aaron Cowen | 5.50% | 3,680,921 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Montanova Capital, LLC
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · May 2, 2025
- Schedule 13G · Montanova Capital, LLC · Jan 6, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026